201-203-C18-12566.EME-NOTA CLINICA-Iglesias_C10-12346.EME ORIGINAL-Fernandez 01/10/13 08:10 Página 201 CASE REPORT Superwarfarin rodenticide intoxication in adults: an update on bromadiolone, brodifacoum, and difethialone MARÍA LUISA IGLESIAS LEPINE1,2, FRANCISCO EPELDE GONZALO1, FRANCISCO CASAÑAS FERRER1, EMILI GENÉ TOUS1,3 Servicio de Urgencias, Hospital de Sabadell, Corporació Sanitària i Universitària Parc Taulí, Sabadell, Barcelona, Spain. 2Departamento de Psiquiatría y Medicina Legal (UAB), Barcelona, Spain. 3CIBERehd, Instituto de Salud Carlos III, Barcelona, Spain. 1 CORRESPONDENCE: María Luisa Iglesias Lepine Servicio de Urgencias Hospital de Sabadell Parc Taulí, s/n 08208 Sabadell Barcelona, Spain E-mail: miglesias@tauli.cat We report 3 cases in which adults used a superwarfarin rodenticide (bromadiolone, brodifacoum, or difethialone) to attempt suicide. No patient developed coagulation abnormalities or significant clinical problems, and all were dischanged alive from the emergency department (2 to home, 1 to a psychiatric facility). An updated action plan based on case reports published in the last 10 years is also provided. [Emergencias 2013;25:201-203] Keywords: Superwarfarin rodenticides. Bromadiolone. Brodifacoum. Difethialone. RECEIVED: 7-9-2011 ACCEPTED: 20-10-2011 CONFLICT OF INTEREST: The authors declare no conflict of interest in relation with the present article. Introduction In Spain, 416 formulated rodenticides are currently registered1 and those most widely used are potent anticoagulants. They are classified into two groups according to their chemical composition: coumarin derivatives (brodifacoum, bromadiolone, coumatetralyl, difenacoum, difethialone, flocoumafen and warfarin) constituting 87.4% and indandione derivatives (diphacinone and chlorophacinone) constitute the remaining 12.6%. However, it is clinically useful to classify them by their half-life: first generation or short duration rodenticide (eg, warfarin) and second-generation or long duration rodenticides (i.e. bromadiolone). The aim of this clinical note is to present three cases of poisoning by ingestion of superwarfarín rodenticides in adults as well as to provide an update on the plan of action to be followed. Clinical cases Case 1 was a 21 year-old woman with a histoEmergencias 2013; 25: 201-203 ry of unwanted 8-week pregnancy, dissociative crises and difficulty in handling stress. She consulted for ingestion of two packets of 0.005% bromadiolone with suicidal intent. The total dose ingested was 2.5 mg some 6-8 h before arrival at the ED. Blood pressure (BP) was 154/86 mmHg and heart rate (HR) 83 beats per minute (lpm). Physical examination, laboratory tests including coagulation tests were normal. The patient was prophylactically administered 20 mg phytomenadione (VK 1) by intravenous (IV) route and kept under observation for 48 h with monitoring of prothrombin time (PT) every 24 h. No significant alterations appeared and she was discharged home. Case 2 was a 57 year-old with a history of bipolar disorder receiving lithium treatment. The patient consulted after ingesting 8 packets of 0.01% brodifacoum with suicidal intent. The total dose ingested was 5 mg during the last week. BP was 100/60 mm / Hg, heart rate 70 bpm and O2 saturation 99% (with an inspired fraction of 26%). On examination, there was evidence of 201 201-203-C18-12566.EME-NOTA CLINICA-Iglesias_C10-12346.EME ORIGINAL-Fernandez 01/10/13 08:10 Página 202 M. L. Iglesias-Lepine et al. epistaxis which required anterior tamponade. Laboratory tests, coagulation tests, lithium levels and ECG were normal. VK1 20 mg IV was administered every 24 h and the patient was kept under observation for 48 h with 12 h monitoring of PT. No significant alterations were observed, the epistaxis was deemed not to be related with a bleeding disorder, and the patient was admitted to the psychiatric ward. Case 3 was a 43 year-old man with a history of personality disorder, alcohol and benzodiazepine dependence. He consulted after ingesting four 25 g packets of 0.0025% difethialone with suicidal intent. Total dose ingested was 2.5 mg in the preceding 3 days. The last use was 8 hours before arrival at the ED. BP was 110/73 mm / Hg, heart rate of 112 bpm and O 2 saturation 97% (with an inspired fraction of 26%). Laboratory tests, coagulation tests, ECG and chest X-ray were normal. The patient was administered 20 mg VK1 IV prophylactically and kept under observation for 48 h with 24 h PT monitoring. No significant changes were observed and the patient was discharged home. Discussion Rodenticide poisoning with superwarfarín has increased in the last decade in countries like the U.S. and China 2,3, as opposed to Spain where prevalence is low4. These products are characterized by their rapid and complete absorption rate and long elimination half-life. As VK1 antagonists, they inhibit VK1 enzymes, 2-3-epoxide reductase and VK1 reductase and decrease production of vitamin K-dependent coagulation factors (II, VII, IX and X)5-7. Protein binding is 99%, and their volume of distribution is 11-12% of bodyweight. They accumulate in the liver due to high lipid solubility, present enterohepatic circulation and are eliminated in feces and urine5,6. The approach to probable / possible rodenticide poisoning for emergency department (ED) professionals is detailed below. The first step is to identify the product and the dose ingested. Product catalogs only specify toxic doses for animals and not humans. From a review of published case reports, the toxic dose of brodifacoum is 0.1 to 0.27 mg/kg1,8 and 0.17 mg/Kg9 for bromadiolone. There are no data on difethialone toxic values. In countries like the U.S. with its American Association of Poison Control Center 8, EDs have screening test for warfarin compounds (Ratio VK12, 3 epoxide/K1)10 and can also identify, quantify 202 and weigh the various superwarfarin compounds using chromatographic techniques5,8,9,11-14. Individual metabolism (genetic variability within populations) of each product guides the clinician on what action to take. Thus the kinetic model of bromadiolone elimination from the blood is bicompartmental, with an initial phase of rapid elimination (3.5 / 6 days in plasma / blood, respectively), followed by a slower terminal phase (10-13/24 days plasma / blood9,13,15. By contrast that of brodifacoum is 20-209 days in serum2,12,16,17. Being multi-compartmental it follows a first-order kinetic model that becomes zero order when intake is significant 7,18 . It has been demonstrated that 10 ng / mL bromadiolone in plasma and and 4-10 ng / mL brodifacoum in serum do not require specific treatment 7,9,18, so not all require ingested doses treatment. The second step is to find out the time since the last ingestion for the possible manifestations that appear at 24-48 h after PT drops below 20%2-6,8-20, i.e. epistaxis, gingival bleeding, hematuria, ecchymosis, hemoptysis, vaginal bleeding, pulmonary or gastrointestinal bleeding, etc. Specific and adjuvant treatment, as for any acute intoxication, is digestive decontamination with activated carbon or polyethylene glycol solution depending on the time elapsed since ingestion. If PT is abnormal (50 - 80%), it is advisable to administer 10 mg orally or IV VK1 and PT control every 24 h. If PT is ⱕ 50% and the patient has some sort of bleeding, the recommendation is VK1 0.1-3 mg / kg / day every 6-8 h by oral or IV route2-4,7-10,12,16,19,20. Bruno et al18 demonstrated in an animal model that the ideal dose of VK1 is 3.5 mg / kg / day every 6 hours for at least 48 h by oral route. Today it may be administered intravenously since the solvent that once caused anaphylaxis has been modified. If the situation is life threatening, one can add prothrombin complex6,13 and / or fresh frozen plasma2-20. Once stabilized, if chromatography to identify and quantify the swallowed product is not available, the recommendation is to orally administer 10 mg VK1 every 24 h2-20 during weeks / months, with weekly PT control8. In our review of published cases we found that it takes a significant amount of the product to produce symptoms in humans, so one should only intervene if the dose ingested is actually toxic2-20, and prophylactic VK1 is not recommended if PT shows no significant alterations at 48 h after ingestion8,11,18. In all three cases presented here, it was unknown whether the dose was toxic for humans. PT was requested every 12 - 24 h during Emergencias 2013; 25: 201-203 201-203-C18-12566.EME-NOTA CLINICA-Iglesias_C10-12346.EME ORIGINAL-Fernandez 01/10/13 08:10 Página 203 SUPERWARFARIN RODENTICIDE INTOXICATION IN ADULTS: AN UPDATE ON BROMADIOLONE, BRODIFACOUM, AND DIFETHIALONE 48 h, VK1 was administered prophylactic ally and observation time was 48 h. In the second case prophylaxis was also deemed necessary because of the episode of epistaxis and the prolonged consumption. However, in light of this review, none of the three required VK1 prophylaxis since none showed PT alterations, and furthermore, the dose administered was twice that recommended. In conclusion, superwarfarin rodenticides are over-the-counter products despite their deadly potential. The concept of a toxic dose enunciated by Paracelsus (1493-1541), dosis sola facit venenum, remains valid today, so therapy should not be applied in cases of a non-toxic dose. If necessary, VK1 treatment should be adjusted on the basis of coagulation test results. All patientsvisiting the ED with a coagulation disorder of unknown origen should be screened for a warfarin compound. And if chromatographic techniques are available, quantification of the product will help avoid unnecessary therapies and fatal outcomes. References 1 Moreno J, López J, Jiménez R. El control de los roedores: revisión de los rodenticidas registrados en el ámbito de la sanidad ambiental en España. Rev Esp Salud Pública. 2004;78:5-16. 2 Nelson AT, Hartzell JD, More K, Durming SJ. Ingestion of Superwarfarin Leading to Coagulopathy: A Case Report and Review of the literature. Med Gen Med. 2006;8:41. 3 Shu-Lei Z, Peng L, Ming J, Ye Z, Shu-Tian Z. Upper gastrointestinal hemorrhage caused by superwarfarin poisoning. Wold J Gastroenterology. 2010;16:1680-2. 4 Rodrigo P, Rodríguez V, García JM, Aguilera I. Intento autolítico con superwarfarinas. Rev Esp Anestesiol Reanim. 2005;52:506-7. 5 Olmos V, Lenzken SC, Paz MC, Olivera NM, Clara SD, López M, et al. Cuantificación de brodifacoum, bromadiolone y difenacoum en suero humano por HPLC con detección ultravioleta y fluorométrica. Acta Toxicol Arg. 2004;12:9. 6 Watt BE, Proudfoot AT, Bradberry SM, Vale JA. Anticoagulant rodenticides. Toxicol Rev. 2005;24:259-69. 7 North Dakota Poison Center. Long-Acting Anticoagulant Rodenticides. Newsletters and Reviews. (Consultado 10 Julio 2011). Disponible en: http://www.ndpoison.org/index.asp?pageID=150. 8 Dolin EK, Baker DL, Buck SC. A 44-year-old woman with hematemesis and cutaneous hemorrhages as a result f superwarfarin poisoning. J Am Osteopath Assoc. 2006;106:280-4. 9 Lo VM, Ching CK, Chan AY, Mak TW. Bromadiolone toxicokinetics: diagnosis and treatment implications. Clin Toxicol (Phila). 2008;46:703-10. 10 Tsutaoka BT, Miller M, Fung SM, Patel MM, Olson KR. Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy. Pharmacotherapy. 2003;23:1186-9. 11 Chua JD, Friedenberg WR. Superwarfarin Poisoning. Arch Intern Med. 1998;158:1929-32. 12 Olmos V, López CM. Brodifacoum poisoning with toxicokinetics data. Clin Toxicol (Phila). 2007;45:487-9. 13 Grobosch T, Angelow B, Schönberg L, Lampe D. Acute bromadiolone intoxication. J Anal Toxicol. 2006;30:281-6. 14 Jin MC, Ren YP, Xu XM, Chen XH. Determination of bromadiolone in whole blood by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Forensic Sci Int. 2007;17:52-6. 15 Vindenes V, Karinen R, Hasvoid I, Bernard HP, Morland JG, Christophersen AS. Bromadiolone poisoning: LC-MS method and pharmacokinetic data. Forensic Sci. 2008;53:993-6. 16 Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol. 2007;82:65660. 17 Pavlu J, Harrington DJ, Voong K, Savidge GF, Jan-Mohamed S, Kaczmarski R. Superfarfaring poisoning. Lancet. 2005;365:628. 18 Bruno GR, Howland MA, McMeeking A, Hoffman R. Long-Acting Anticoagulant Overdose: Brodifacoum Kinetics and Optimal Vitamin K. Ann Emerg Med. 2000;36:262-7. 19 Laposata M, Van Cott E, Lev MH. Case 1-2007: A 40 years-Old Woman with Epixtasis, Hematemesis and Altered Mental Status. N Engl J Med. 2007;356:174-82. 20 Conte G, Torres C, Alfaro J, Marianela V. Intoxicación por rodenticida-superwarfarina: Descripción de un caso clínico. Revista Hospital Clínico Universidad de Chile. 2004;15:209-12. Intoxicación por rodenticidas superwarfarínicos en adultos: bromadiolona, brodifacoum y difetialona Iglesias-Lepine ML, Epelde Gonzalo F, Casañas Ferrer F, Gene Tous E Se presentan tres casos clínicos de tentativas suicidas por ingesta de rodenticidas superwarfarínicos (bromadiolona, brodifacoum y difetialona) en tres pacientes adultos. Ningún paciente presentó alteraciones en la coagulación ni problemas clínicos relevantes, por lo que fueron dados de alta desde urgencias (2 casos a domicilio y 1 caso con ingreso en psiquiatría). Se realiza una puesta al día del plan de actuación a seguir, en base a los casos clínicos publicados en los últimos diez años. [Emergencias 2013;25:201-203] Palabras clave: Rodenticidas superwarfarínicos. Bromadiolona. Brodifacoum y difetialona. Emergencias 2013; 25: 201-203 203